Histone deacetylation: an important mechanism in inflammatory lung diseases.
about
New insights into insulin: The anti-inflammatory effect and its clinical relevanceNuclear receptor coregulators: modulators of pathology and therapeutic targetsNF-kappaB Signaling in Chronic Inflammatory Airway DiseaseAdvancements in the delivery of epigenetic drugsHyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal ratsAntifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive ratsEffect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model.Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells.Modulation of cystic fibrosis lung disease by variants in interleukin-8.Zinc deprivation mediates alcohol-induced hepatocyte IL-8 analog expression in rodents via an epigenetic mechanismMaternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammationAcute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney diseaseHistone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD PatientsEvaluation of multidrug resistance-1 gene C>T polymorphism frequency in patients with asthma.Role of GSTM1 in resistance to lung inflammation.The Flavonoid 7,4'-Dihydroxyflavone Inhibits MUC5AC Gene Expression, Production, and Secretion via Regulation of NF-κB, STAT6, and HDAC2.Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia.Treating COPD with PDE 4 inhibitors.Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesisGene-environment interaction effects on lung function- a genome-wide association study within the Framingham heart study.Epigenetic modifications as therapeutic targets.The importance of epigenetics in the development of chronic obstructive pulmonary disease.Why do anti-inflammatory therapies fail to improve insulin sensitivity?Lysine acetylation in obesity, diabetes and metabolic disease.Histone deacetylases and their role in asthma.Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders.A review of mometasone furoate / formoterol in the treatment of asthma.Histone mimics: digging down under.Epigenetic dysfunctional diseases and therapy for infection and inflammation.A DNA methyltransferase modulator inspired by peyssonenyne natural product structures.Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation.β-Catenin Directs Nuclear Factor-κB p65 Output via CREB-Binding Protein/p300 in Human Airway Smooth Muscle.Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences.Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2.The role of HDAC2 in cigarette smoke-induced airway inflammation in a murine model of asthma and the effect of intervention with roxithromycin.The Flavonoid 7,4'-Dihydroxyflavone Prevents Dexamethasone Paradoxical Adverse Effect on Eotaxin Production by Human Fibroblasts.Effects of retinoic acid and butyric acid on the expression of prestin and Gata-3 in organotypic cultures of the organ of corti of newborn rats.Phytoceuticals: the new 'physic garden' for asthma and chronic obstructive pulmonary disease.HDAC2 is required by the physiological concentration of glucocorticoid to inhibit inflammation in cardiac fibroblasts.
P2860
Q26822374-F2059B91-40E9-4F8C-A16C-E10DA1C4DF76Q26859163-BFDAFC29-7C7A-42BE-B2F9-ECAA523AF25EQ27009696-0F8CB5FD-A236-4C7D-BDE7-DDB140E1C5D8Q28088478-67C6E1FD-ACF6-4D04-99BD-97022B3D1F38Q28579280-7760ABD5-367B-47A7-9A5F-37DE2D5A638FQ33772867-ACDA3FCD-00B4-43FD-A210-33431C97B9DAQ33988560-D43A1F09-ACE9-4425-8E7D-2B0F56794ADEQ34490868-9EBDC9DA-31E6-403C-AB1D-EA7E2F9811C9Q34629056-73470A24-208C-495A-BB50-CEF556E3CE8FQ35168162-7A774CFC-57EE-4F65-81CD-61FEA43747A1Q35327025-F8B15892-6582-4768-A965-8CBD8FF73A7DQ35601604-1411A615-CEAC-465E-9467-C9748C15FABCQ35893218-46D52D18-9E8D-49EF-88A8-19A16A1C6B89Q35904081-416E1BBA-0342-4A06-86BD-34A219DEFDEFQ36150526-959FC81E-614C-4DB3-A9AD-23D02E4A33AFQ36162231-F131F002-46F1-427C-8561-DDED9950E2E6Q36445507-563FEA62-04FB-4110-9DA6-C482857DD1D2Q36465605-AAC29EC3-B2C7-4EF3-9774-5D0D452AA44DQ37082594-E95BC49B-A80F-4216-BEF9-BBC1E393C1A2Q37130888-25691178-CA67-473E-B7A0-733CBFA88742Q37438727-DCDA03D4-322F-4FC6-8B15-9D7BB9B5B09DQ37800011-29D9AA80-6796-4DB6-BD37-696FAF4889C4Q37913490-24988B9F-CAA3-4A23-B0A3-AED37B5CA6B1Q37950733-6FEC70B1-5DBB-41ED-98EF-6B73F731752EQ37956175-8616776C-8CB4-4EB3-8704-50F4F7651D6BQ37974680-7D59DB3E-AF99-4021-BEBE-36E17B45DA7BQ38064312-3214EA61-001F-4171-BA98-5952AC30CD10Q38077842-37041AF1-5740-480B-A6EF-90F4E3DEA155Q38223397-FB8E2B63-8231-4A05-9DAB-CF36C3A2D1FDQ39029869-247ED5CA-F61F-4486-B48E-2E5E6C22E610Q39263507-1C2F6720-25BC-4B3D-99FB-2EDAF53EE7BBQ40091089-7640C431-3FB1-4A40-B2F9-83382E44E22EQ41699533-C5ACBEFF-8406-415A-8313-8DC755306830Q42427086-B682DC19-A5FB-4D71-959B-DA66B7AE78CEQ42971728-DE32985B-A55D-4339-AA3C-2AB98B7A58EBQ47727979-3A4D9E06-4BC8-4F13-A6A9-E20E59C42CF1Q47994498-86431718-153F-4326-9E11-F20679B4A0B7Q50434868-B438B16C-9993-4D6F-9EDD-92CE5F2419C1Q50663550-C2FCB3EC-8DA1-41ED-9F08-CC80156D17E5Q52868613-2FD7CA36-7E2A-4C77-8ACC-76D4B1F472CA
P2860
Histone deacetylation: an important mechanism in inflammatory lung diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@ast
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@en
type
label
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@ast
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@en
prefLabel
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@ast
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@en
P2093
P2860
P1476
Histone deacetylation: an important mechanism in inflammatory lung diseases.
@en
P2093
Ian M Adcock
Kazuhiro Ito
Peter J Barnes
P2860
P304
P356
10.1080/15412550500346683
P407
P577
2005-12-01T00:00:00Z